Paper Details

  1. Home
  2. Paper Details

[Results of a cooperative prospective study of treatment of primary digestive localizations of non-Hodgkin's lymphoma].

Author: AegerterP, LecomteD, NajmanA, ParlierY

English AbstractA summary of a research paper/publication written in English for a wider audience.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

A study of 82 patients with primary digestive lymphoma found that chemotherapy was effective, resulting in a 63% complete remission rate. Survival at 5 years was 46%. Factors influencing survival included the extent of the disease, tumor grade, initial location (gastric lymphoma had the best survival), and achievement of complete remission. While chemotherapy was effective, the role of surgery in managing lymphomas requires further investigation.
Paper Details　
Original Abstract of the Article :
We report the results of chemotherapy treatment in 82 patients presenting with primary digestive lymphoma and included in a study conducted between October 1977 and October 1985. There were 31 gastric lymphoma, 18 small intestinal lymphomas, and 19 with multiple involvement: 63 patients had had a su...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/3830804

データ提供：米国国立医学図書館（NLM）

Combating Digestive Lymphomas: A Collaborative Effort

The digestive system is a vast desert, and sometimes unwelcome invaders like lymphomas can take root in this terrain. This study explores the effectiveness of [chemotherapy] in treating [primary digestive lymphomas] using a [cooperative prospective study] approach. The researchers analyzed data from 82 patients and found that [chemotherapy was effective in achieving complete remission in 63% of patients]. They also noted that [survival was dependent on several factors], including the extent of the disease, the grade of the lymphoma, and the initial location. This study provides valuable insights into the treatment of digestive lymphomas and underscores the importance of a comprehensive approach to combatting these formidable invaders.

Chemotherapy: A Powerful Weapon in the Fight Against Digestive Lymphomas

This study demonstrates that chemotherapy can be an effective tool in the fight against digestive lymphomas, achieving complete remission in a significant percentage of patients. The research also highlights the importance of considering various factors, such as the stage and grade of the lymphoma, to personalize treatment plans.

Navigating the Desert of Digestive Lymphoma Treatment: A Collaborative Journey

The desert of digestive lymphoma treatment can be challenging, but this study provides valuable guidance for navigating this terrain. The findings suggest that chemotherapy can be a potent weapon in combating these diseases. This collaborative study demonstrates the power of research, collaboration, and personalized care in improving outcomes for patients facing this formidable challenge.

Dr. Camel's Conclusion

This study provides valuable data on the effectiveness of chemotherapy in treating primary digestive lymphomas, highlighting its role in achieving complete remission and the importance of individualized treatment plans. The journey through digestive lymphoma treatment is a complex one, and this research offers a valuable guidepost for understanding the different factors that influence outcomes and the importance of collaborative efforts to combat these diseases.

Date :
  1. Date Completed 1986-04-29
  2. Date Revised 2006-11-15
Further Info :

Pubmed ID

3830804

DOI: Digital Object Identifier

3830804

Related Literature

Article Analysis
・Effective treatment of lymphoma
SNS
PICO Info
in preparation
Languages

French

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.